Background: Fertility Awareness Method (FAM) cost-effective and the safest contraceptive method yet it is rarely used. Objectives: A) Familiarize women, and clinicians with the enhancement to the fertility awareness method. B) Persuade investigators to validate this pilot study by providing additional research. C) Allow women to pinpoint the precise day of ovulation. Materials and Methods: We recruited 40 healthy women with regular periods to participate in this pilot research for 3 months. 20 used the traditional FAM with basal body temperature and fertile cervical mucus. The other 20 women used the conforming vaginal cap to collect their fertile cervical mucus (Spinnbarkeit). Starting at day 9 they collected samples directly from the cervix until they detected fertile mucus. We also instructed them to record their findings and any side effects. Results: Women using the vaginal conforming cap identified preovulatory fertile cervical secretions in 95% of cases. They also verified ovulation with a positive urinary L.H. (Luteinizing Hormone) surge. Basal Body Temperature charts were biphasic and consistent with the L.H. surge results. The control group who used the subjective detection were only 55% successful. Conclusions: Collecting mucus directly from the cervix yielded a large quantity and excellent quality of (Spinnbarkeit). This allowed women to pinpoint the day of ovulation with astonishing precision. This shortened the fertile window to 4 days for conception and 9 days for contraception. The Synergy created between the vaginal conforming cap and a Smartphone application will provide the safest, most cost-effective birth control without side effects
This article addresses three unmet women’s reproductive health needs, and how the FemCap can fulfill these needs. The FemCap is an FDA-approved, non-hormonal contraceptive device that can accommodate some deficient areas of women’s health: 1. A scarcity of hormone-free contraceptive methods. 2. Enhancement of fertility awareness method that is infrequently used but is the safest method. 3. Help Millions of women who suffer silently from stress urinary incontinence. The FemCap blocks sperm from entering the cervix. It is time-tested to be safe and effective for contraception. Using the FemCap directly at the cervix, it can collect the fertile cervical mucus without mixing it with any other vaginal fluid. Current pessaries used to treat stress urinary incontinence (SUI) have significant drawbacks, including displacement, erosion, ulceration, of the vagina and urethral blockage. The rim of the FemCap performs the same function as the ring pessary by supporting the bladder neck. The outward flared brim restores the urethra and vaginal anatomy. At the same time, the bowl of the FemCap keep the cervix from prolapsing further. The FemCap is a long-established barrier method of contraception, and pilot studies results show it can improve fertility awareness methods and manage Stress Urinary Incontinence. It would be ideal and cost-effective to have a single reusable device with several functions for contraceptives, increasing the acceptability and effectiveness of fertility awareness methods, and stress urinary incontinence control. The FemCap would be an ideal alternative to the condom.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.